Exploring response signals and targets in aggressive unresectable hepatocellular carcinoma: an analysis of targeted therapy phase 1 trials

PURPOSE: Patients with advanced hepatocellular carcinoma (HCC) have limited effective therapeutic options. Given the rapid advanced in drug development and emergence of novel agents, we analyzed the characteristics and outcomes of HCC patients treated on early phase trials with an emphasis on target...

Descripción completa

Detalles Bibliográficos
Autores principales: Subbiah, Ishwaria M., Falchook, Gerald S., Kaseb, Ahmed O., Hess, Kenneth R., Tsimberidou, Apostolia M., Fu, Siqing, Subbiah, Vivek, Hong, David S., Naing, Aung, Sarina, A. Piha-Paul, Akmal, Owais, Janku, Filip, Kurzrock, Razelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695071/
https://www.ncbi.nlm.nih.gov/pubmed/26164085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695071/
https://www.ncbi.nlm.nih.gov/pubmed/26164085

Ejemplares similares